Evidence map›Paper›PMID 21811412›Full record

ArticlePLoS genetics2011

Expression of arf tumor suppressor in spermatogonia facilitates meiotic progression in male germ cells.

Michelle L Churchman, Ignasi Roig, Maria Jasin, Scott Keeney, Charles J Sherr

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. p53 Controls Meiotic Prophase Progression and Crossover Formation.International journal of molecular sciences · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Aging of spermatogonial stem cells by Jnk-mediated glycolysis activation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  9. Review
  10. Article
  11. Article
  12. Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects ofProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  13. Article
  14. Elimination of p19JCI insight · 2016
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Michelle L ChurchmanHoward Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Ignasi Roig
Maria Jasin
Scott Keeney
Charles J Sherr
Howard Hughes Medical Institute · USMemorial Sloan Kettering Cancer Center · USUniversitat Autònoma de Barcelona · ES

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Role of Spo11 and recombination in mouse meiosisR01HD040916 · NICHD · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI JASIN, MARIA · 2001 to 2011
$5.4M
Howard Hughes Medical InstituteNCI NIH HHS CA-21765NCI NIH HHS P30 CA021765NICHD NIH HHS R01 HD040916NICHD NIH HHS R01 HD-40916
6 · The paper itself

Abstract

The mammalian Cdkn2a (Ink4a-Arf) locus encodes two tumor suppressor proteins (p16(Ink4a) and p19(Arf)) that respectively enforce the anti-proliferative functions of the retinoblastoma protein (Rb) and the p53 transcription factor in response to oncogenic stress. Although p19(Arf) is not normally detected in tissues of young adult mice, a notable exception occurs in the male germ line, where Arf is expressed in spermatogonia, but not in meiotic spermatocytes arising from them. Unlike other contexts in which the induction of Arf potently inhibits cell proliferation, expression of p19(Arf) in spermatogonia does not interfere with mitotic cell division. Instead, inactivation of Arf triggers germ cell-autonomous, p53-dependent apoptosis of primary spermatocytes in late meiotic prophase, resulting in reduced sperm production. Arf deficiency also causes premature, elevated, and persistent accumulation of the phosphorylated histone variant H2AX, reduces numbers of chromosome-associated complexes of Rad51 and Dmc1 recombinases during meiotic prophase, and yields incompletely synapsed autosomes during pachynema. Inactivation of Ink4a increases the fraction of spermatogonia in S-phase and restores sperm numbers in Ink4a-Arf doubly deficient mice but does not abrogate γ-H2AX accumulation in spermatocytes or p53-dependent apoptosis resulting from Arf inactivation. Thus, as opposed to its canonical role as a tumor suppressor in inducing p53-dependent senescence or apoptosis, Arf expression in spermatogonia instead initiates a salutary feed-forward program that prevents p53-dependent apoptosis, contributing to the survival of meiotic male germ cells.

Indexed as

AnimalsApoptosisCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p16FemaleFluorescent Antibody TechniqueFollicle Stimulating HormoneHistonesImmunoblottingLuteinizing HormoneMaleMeiosisMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicCdkn2a protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p16Dmc1 protein, mouseFollicle Stimulating Hormonegamma-H2AX protein, mouseHistonesLuteinizing HormoneNuclear ProteinsPhosphate-Binding ProteinsRad51 RecombinaseTumor Suppressor Protein p53

Identifiers

PMID21811412
PMCPMC3141002
OpenAlexW2066062365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.